These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30796939)

  • 1. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
    Mavrogianni C; Lambrinou CP; Androutsos O; Lindström J; Kivelä J; Cardon G; Huys N; Tsochev K; Iotova V; Chakarova N; Rurik I; Moreno LA; Liatis S; Makrilakis K; Manios Y;
    Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study.
    Manios Y; Mavrogianni C; Lambrinou CP; Cardon G; Lindström J; Iotova V; Tankova T; Civeira F; Kivelä J; Jancsó Z; Shadid S; Tsochev K; Mateo-Gallego R; Radó S; Dafoulas G; Makrilakis K; Androutsos O;
    BMC Endocr Disord; 2020 Mar; 20(Suppl 1):12. PubMed ID: 32164646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.
    Rokhman MR; Arifin B; Zulkarnain Z; Satibi S; Perwitasari DA; Boersma C; Postma MJ; van der Schans J
    PLoS One; 2022; 17(7):e0269853. PubMed ID: 35862370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of undiagnosed prevalent type 2 diabetes - The Danish General Suburban Population Study.
    Heltberg A; Andersen JS; Sandholdt H; Siersma V; Kragstrup J; Ellervik C
    Prim Care Diabetes; 2018 Feb; 12(1):13-22. PubMed ID: 28964672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
    BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a Finnish Diabetes Risk Score in detecting undiagnosed diabetes among Kenyans aged 18-69 years.
    Mugume IB; Wafula ST; Kadengye DT; Van Olmen J
    PLoS One; 2023; 18(4):e0276858. PubMed ID: 37186010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic, anthropometric, and lifestyle correlates of prediabetes and type 2 diabetes in europe: The Feel4Diabetes study.
    Kontochristopoulou AM; Karatzi K; Karaglani E; Cardon G; Kivelä J; Wikström K; Iotova V; Tsochev K; Tankova T; Rurik I; Radone AS; Liatis S; Makrilakis K; Moreno LA; Manios Y
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1851-1862. PubMed ID: 35610084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population.
    Agarwal G; Guingona MM; Gaber J; Angeles R; Rao S; Cristobal F
    BMC Public Health; 2019 Aug; 19(1):1169. PubMed ID: 31455247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population.
    Gannar F; Rodriguez-Pérez MDC; Domínguez Coello S; Haouet K; Brito Díaz B; Cabrera de León A
    PLoS One; 2018; 13(8):e0200718. PubMed ID: 30110336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe.
    Gabriel R; Acosta T; Florez K; Anillo L; Navarro E; Boukichou N; Acosta-Reyes J; Barengo NC; Lindström J; Tuomilehto JO; Aschner P
    Diabetes Res Clin Pract; 2021 Aug; 178():108976. PubMed ID: 34302911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes].
    Peralta HM; Costa Gil JE; Saleme AE
    Medicina (B Aires); 2024; 84(1):1-10. PubMed ID: 38271927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a Peruvian hospital health care workers sample.
    Yovera-Aldana M; Mezones-Holguín E; Agüero-Zamora R; Damas-Casani L; Uriol-Llanos B; Espinoza-Morales F; Soto-Becerra P; Ticse-Aguirre R
    PLoS One; 2024; 19(8):e0299674. PubMed ID: 39110713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of undiagnosed hyperglycaemia in the dental setting: The DiabetRisk study. A field trial.
    Montero E; Matesanz P; Nobili A; Luis Herrera-Pombo J; Sanz M; Guerrero A; Bujaldón A; Herrera D;
    J Clin Periodontol; 2021 Mar; 48(3):378-388. PubMed ID: 33263197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.